Skip to main content
. 2020 Feb 7;38(14):1518–1526. doi: 10.1200/JCO.19.02408

FIG 2.

FIG 2.

(A) Overall survival. The 4-year probability of overall survival was 58% (95% CI, 53% to 64%) for haploidentical bone marrow (BM) transplantations, 59% (95% CI, 50% to 68%) for haploidentical peripheral-blood (PB) transplantations, and 49% (95% CI, 42% to 56%) for unrelated cord blood (UCB) transplantations. (B) Progression-free survival. The 4-year probability of progression-free survival was 46% (95% CI, 41% to 52%) for haploidentical BM transplantations, 52% (95% CI, 43% to 61%) for haploidentical PB transplantations, and 36% (95% CI, 30% to 43%) for UCB transplantations. Haplo, haploidentical.